Urology News and Research

Latest Urology News and Research

Dogs accurately detect prostate cancer

With an accuracy rating of 98 percent, specially-trained dogs were able to smell volatile organic compounds (VOCs) released into urine by prostate tumors, setting the stage for a potentially new means of early prostate cancer detection.

19 May 2014

Cook Medical to exhibit augmented reality experiences at AUA meeting

Cook Medical will exhibit augmented reality experiences, which is a technology used to simulate use of products, and host a skills challenge at their booth, #1617, at the annual American Urological Association meeting.

From COOK MEDICAL INC. 16 May 2014

TOLMAR Pharmaceuticals holds exclusive distribution rights to ELIGARD in the U.S. and Puerto Rico

TOLMAR Pharmaceuticals, Inc., focused on specialty pharmaceutical products, today announced that, effective May 8, 2014, the company holds exclusive distribution rights to ELIGARD® (leuprolide acetate for injectable suspension) in the U.S. and Puerto Rico.

16 May 2014

Men with sperm abnormalities at increased risk of dying sooner, study finds

Men who are infertile because of defects in their semen appear to be at increased risk of dying sooner than men with normal semen, according to a study led by a researcher at the Stanford University School of Medicine.

16 May 2014

Actavis reaches agreement to continue supplying authorized generic version of JPI's Concerta

Actavis plc today announced that it has reached an agreement with Janssen Pharmaceuticals, Inc. to continue supplying the authorized generic version of JPI's Concerta (methylphenidate hydrochloride extended-release tablets).

15 May 2014

Treating older men with early-stage prostate cancer does not help live longer

Treating older men with early-stage prostate cancer who also have other serious underlying health problems with aggressive therapies such as surgery or radiation therapy does not help them live longer and, in fact, can be detrimental, according to a study by UCLA researchers.

13 May 2014

Inflammation may accentuate age-related bladder function decline

Age-associated biochemical changes in the bladder may accentuate the inflammation associated with overactive bladder, study findings indicate.

12 May 2014

RPCI research finds patients with metastatic kidney cancer benefit from HDIL-2 immunotherapy

A retrospective study published online ahead of print in the medical journal Urology by a physician team from Roswell Park Cancer Institute (RPCI) found that patients with metastatic kidney cancer — even those with chronic renal insufficiency — can tolerate and benefit from a treatment called high-dose interleukin-2 (HDIL-2) immunotherapy.

7 May 2014

Overactive bladder, mental illness prevalent in young female war veterans

Overactive bladder symptoms are present in nearly one in four female veterans returning from overseas military service, US researchers say.

6 May 2014

Findings suggest usage of statins after surgery may reduce risk of prostate cancer recurrence

Men who begin taking statins after prostate cancer surgery are less likely to have a recurrence of their cancer, according to a retrospective analysis led by researchers at Duke Medicine.

2 May 2014

Possible link between aggressive prostate cancer and vitamin D deficiency

Vitamin D deficiency was an indicator of aggressive prostate cancer and spread of the disease in European-American and African-American men who underwent their first prostate biopsy because of abnormal prostate-specific antigen (PSA) and/or digital rectal examination (DRE) test results, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

1 May 2014

Noninvasive technique detects prostate cancer using an electronic nose

We may soon be able to make easy and early diagnoses of prostate cancer by smell. Investigators in Finland have established that a novel noninvasive technique can detect prostate cancer using an electronic nose. In a proof of principle study, the eNose successfully discriminated between prostate cancer and benign prostatic hyperplasia (BPH) by "sniffing" urine headspace (the space directly above the urine sample). Results using the eNose are comparable to testing prostate specific antigen (PSA), reports the Journal of Urology.

1 May 2014

Actavis’ net revenue increases 40% to $2.66B in Q1 2014

Actavis plc today reported net revenue increased 40 percent to $2.66 billion for the first quarter ended March 31, 2014, compared to $1.90 billion in the first quarter 2013.

30 Apr 2014

Study documents occupational exposure to waste anesthetic gases in PACU

Teleflex Incorporated (NYSE: TFX): A study published in the Journal of PeriAnesthesia Nursing (JOPAN) documents occupational exposure to waste anesthetic gases (WAG) in the post-anesthesia care unit (PACU) may be higher than standards recommend.

29 Apr 2014

Elsevier and AUA collaborate to launch new journal, Urology Practice

Elsevier, world-leading provider of scientific, technical and medical information products and services, and the American Urological Association (AUA), a premier urological association providing invaluable support to the urology community, announce their collaboration to launch a new journal, Urology Practice.

29 Apr 2014

Actavis' subsidiary files lawsuit against FDA over Celebrex decision

Actavis plc today announced that its subsidiary, Watson Laboratories, Inc., has filed suit against the U.S. Food and Drug Administration challenging the Agency's decision regarding its entitlement to shared 180-day marketing exclusivity for its generic version of Celebrex (celecoxib) 50 mg, 100 mg, 200 mg and 400 mg capsules.

29 Apr 2014